ropinirol
Sign in to saveRopinirole, sold under the brand name Requip among others, is a medication used to treat Parkinson's disease (PD) and restless legs syndrome (RLS). It is taken by mouth.
Research
1,116 papers- Ropinirole.2006
- Phase 1/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery.Cell stem cell · 2023
- [Ropinirol: a new dopamine agonist in the treatment of Parkinson's disease].Neurologia (Barcelona, Spain) · 1997
- [Systemic review and meta-analysis of tolerability and safety between different titration regimes of ropinirol dose in the treatment of Parkinson's disease].Neurologia (Barcelona, Spain) · 2007
- Dopamine agonists.The Medical clinics of North America · 1999
via PubMed
Article
11 sectionsContents
- Medical uses
- Side effects
- Pharmacology
- Pharmacodynamics
- Pharmacokinetics
- Chemistry
- History
- Society and culture
- Lawsuit
- See also
- References
Ropinirole, sold under the brand name Requip among others, is a medication used to treat Parkinson's disease (PD) and restless legs syndrome (RLS). It is taken by mouth.
Common side effects include sleepiness, vomiting, and dizziness. Serious side effects may include pathological gambling, hypersexuality, low blood pressure with standing and hallucinations. Use in pregnancy and breastfeeding is of unclear safety. It is a dopamine agonist and works by triggering dopamine D2 receptors.